Foscarnet: Difference between revisions
ClaireLewis (talk | contribs) (Created page with "==Administration== *Type: Antiviral *Dosage Forms: *Routes of Administration: IV *Common Trade Names: Foscavir ==Adult Dosing== *CMV retinitis: 90 mg/kg IV q12h OR 60 mg/kg I...") |
ClaireLewis (talk | contribs) |
||
| Line 1: | Line 1: | ||
==Administration== | ==Administration== | ||
*Type: Antiviral | *Type: [[Antiviral]] | ||
*Dosage Forms: | *Dosage Forms: | ||
*Routes of Administration: IV | *Routes of Administration: IV | ||
Revision as of 23:09, 25 February 2017
Administration
- Type: Antiviral
- Dosage Forms:
- Routes of Administration: IV
- Common Trade Names: Foscavir
Adult Dosing
- CMV retinitis: 90 mg/kg IV q12h OR 60 mg/kg IV q8h for 2-3 weeks, then maintenance 90-120 mg/kg IV daily
- HSV resistant to acyclovir, immunocompromised: 40 mg/kg IV 2-3 times daily
- VZV resistant to acyclovir, HIV+: 90 mg/kg IV q12h
Pediatric Dosing
Special Populations
- Pregnancy Rating: C
- Lactation risk: Infant risk cannot be ruled out
- Renal dosing: Complicated dose adjustment required!
- Hepatic dosing: No adjustement
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- Hyperphosphatemia, hypophosphatemia, hypocalcemia, hypokalemia, hypomagnesemia
- Pancreatitis
- Pancytopenia
- Renal failure, renal impairment
- Seizure
Common
- Nausea, vomiting, diarrhea
- Anemia, granulocytopenic disorder
- Headache
- Fever
Pharmacology
- Half-life: 3.3-4h
- Metabolism:
- Excretion: Renal
Mechanism of Action
- inhibits pyrophosphate binding on viral DNA polymerases